These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26288691)

  • 1. Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.
    Nomura S; Endo-Umeda K; Aoyama A; Makishima M; Hashimoto Y; Ishikawa M
    ACS Med Chem Lett; 2015 Aug; 6(8):902-7. PubMed ID: 26288691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of novel transrepression-selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one skeleton.
    Aoyama A; Endo-Umeda K; Kishida K; Ohgane K; Noguchi-Yachide T; Aoyama H; Ishikawa M; Miyachi H; Makishima M; Hashimoto Y
    J Med Chem; 2012 Sep; 55(17):7360-77. PubMed ID: 22873709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of rosiglitazone for peroxisome proliferator-activated receptor gamma transrepression.
    Toyota Y; Nomura S; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2776-2780. PubMed ID: 28465099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided design of N-phenyl tertiary amines as transrepression-selective liver X receptor modulators with anti-inflammatory activity.
    Chao EY; Caravella JA; Watson MA; Campobasso N; Ghisletti S; Billin AN; Galardi C; Wang P; Laffitte BA; Iannone MA; Goodwin BJ; Nichols JA; Parks DJ; Stewart E; Wiethe RW; Williams SP; Smallwood A; Pearce KH; Glass CK; Willson TM; Zuercher WJ; Collins JL
    J Med Chem; 2008 Sep; 51(18):5758-65. PubMed ID: 18800767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptors as potential therapeutic targets in atherosclerosis.
    Zhu Y; Li Y
    Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
    Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
    Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
    DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER
    J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase (CYP27A1) modulate liver X receptor activity.
    Endo-Umeda K; Yasuda K; Sugita K; Honda A; Ohta M; Ishikawa M; Hashimoto Y; Sakaki T; Makishima M
    J Steroid Biochem Mol Biol; 2014 Mar; 140():7-16. PubMed ID: 24269243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and initial biological evaluation of new mimics of the LXR-modulator 22(S)-hydroxycholesterol.
    Strand OA; Sandberg M; Sylte I; Görbitz CH; Thoresen GH; Kase ET; Rongved P
    Bioorg Med Chem; 2014 Jan; 22(1):643-50. PubMed ID: 24268541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestenoic acid analogues as inverse agonists of the liver X receptors.
    Alvarez LD; Dansey MV; Ogara MF; Peña CI; Houtman R; Veleiro AS; Pecci A; Burton G
    J Steroid Biochem Mol Biol; 2020 May; 199():105585. PubMed ID: 31931135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor modulators: a review of recently patented compounds (2007 - 2009).
    Li X; Yeh V; Molteni V
    Expert Opin Ther Pat; 2010 Apr; 20(4):535-62. PubMed ID: 20302451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold.
    Goher SS; Griffett K; Hegazy L; Elagawany M; Arief MMH; Avdagic A; Banerjee S; Burris TP; Elgendy B
    Bioorg Med Chem Lett; 2019 Feb; 29(3):449-453. PubMed ID: 30587446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ouabagenin is a naturally occurring LXR ligand without causing hepatic steatosis as a side effect.
    Tamura S; Okada M; Kato S; Shinoda Y; Shioda N; Fukunaga K; Ui-Tei K; Ueda M
    Sci Rep; 2018 Feb; 8(1):2305. PubMed ID: 29396543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
    Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
    J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
    Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
    J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and In Vitro Evaluation of Novel Liver X Receptor Agonists Based on Naphthoquinone Derivatives.
    Nishioka T; Endo-Umeda K; Ito Y; Shimoda A; Takeuchi A; Tode C; Hirota Y; Osakabe N; Makishima M; Suhara Y
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of liver X receptor protects inner retinal damage induced by N-methyl-D-aspartate.
    Zheng S; Yang H; Chen Z; Zheng C; Lei C; Lei B
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1168-80. PubMed ID: 25613943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: implications for the development and treatment of atherosclerosis.
    Song C; Hiipakka RA; Liao S
    Steroids; 2001 Jun; 66(6):473-9. PubMed ID: 11182136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.